BIO-key International, Inc. (BKYI) vs DarkIris Inc. Class A Ordinary Shares (DKI)
A side-by-side comparison of BIO-key International, Inc. and DarkIris Inc. Class A Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BKYI
BIO-key International, Inc.
$1.82TechnologyDelayed quote: Oct 6, 2026, 4:00 PM EDT
DKI
DarkIris Inc. Class A Ordinary Shares
$1.36TechnologyDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BKYI vs DKI
growth of $100 · dividends reinvested · last 1yBKYI -74.4% (-74.4%/yr)DKI -98.3% (-98.3%/yr)BKYI compounded faster over this window
Log scale — wide-divergence pair
BKYI DKI
BKYI vs DKI: by the numbers
- •BKYI is the larger company ($2M vs $2M market cap).
- •Both run net losses; BKYI's is the smaller (-50.00% vs -85.75% net margin).
Metrics side by side
Valuation
| Metric | BKYI | DKI |
|---|---|---|
| P/S ratio | 0.29 | N/A |
| P/B ratio | 0.46 | 2.75 |
Profitability
| Metric | BKYI | DKI |
|---|---|---|
| Gross margin | 81.75% | 24.83% |
| Operating margin | -69.89% | -85.29% |
| Net margin | -50.00% | -85.75% |
| ROE | -79.09% | -127.17% |
| ROIC | -70.16% | -126.50% |
Growth (annualized)
| Metric | BKYI | DKI |
|---|---|---|
| Revenue CAGR (5Y) | 7.00% | N/A |
| Total return CAGR (5Y) | -68.40% | N/A |
Go deeper
Dig into the metrics
BIO-key International ROEDarkIris Inc. Class A Ordinary Shares ROEBIO-key International operating marginDarkIris Inc. Class A Ordinary Shares operating marginBIO-key International revenue growthDarkIris Inc. Class A Ordinary Shares revenue growthBIO-key International free cash flowDarkIris Inc. Class A Ordinary Shares free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.